Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $3.3 billion.

  • Fresenius Medical Care AG's Free Cash Flow fell 19.84% to $866.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 11.97%. This contributed to the annual value of $3.3 billion for FY2024, which is 8.00% down from last year.
  • Fresenius Medical Care AG's Free Cash Flow amounted to $3.3 billion in FY2024, which was down 8.00% from $3.6 billion recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Free Cash Flow registered a high of $6.0 billion during FY2020, and its lowest value of $3.0 billion during FY2022.
  • Moreover, its 3-year median value for Free Cash Flow was $3.3 billion (2024), whereas its average is $3.3 billion.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Free Cash Flow surged by 64.30% in 2020, and later plummeted by 34.72% in 2021.
  • Over the past 5 years, Fresenius Medical Care AG's Free Cash Flow (MRY) stood at $6.0 billion in 2020, then crashed by 34.72% to $3.9 billion in 2021, then dropped by 23.39% to $3.0 billion in 2022, then increased by 18.58% to $3.6 billion in 2023, then dropped by 8.00% to $3.3 billion in 2024.
  • Its last three reported values are $3.3 billion in FY2024, $3.6 billion for FY2023, and $3.0 billion during FY2022.